MicroRNA-203 up-regulates nitric oxide expression in temporomandibular joint chondrocytes via targeting TRPV4

Archives of Oral Biology

Volumn 58, Issue 2, 2013, Pages 192-199

  Hu, Fang ^a   Zhu, Wei ^b   Wang, Lin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

(MCCs); 17 oestradiol (E2); Mandibular condylar chondrocytes; MicroRNA 203 (miR 203); Nitric oxide (NO); Transient receptor potential vanilloid 4 (TRPV4)

Indexed keywords

RATTUS;

MICRORNA; NITRIC OXIDE; TRPV4 PROTEIN, RAT; VANILLOID RECEPTOR;

ANIMAL; CARTILAGE CELL; CYTOLOGY; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TEMPOROMANDIBULAR JOINT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHONDROCYTES; FEMALE; IMMUNOHISTOCHEMISTRY; MICRORNAS; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; TEMPOROMANDIBULAR JOINT; TRPV CATION CHANNELS; UP-REGULATION;

EID: 84874115924     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2012.08.013     Document Type: Article

References (43)

1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis and Rheumatism 1986;29(8):1039-49.
2. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nature Reviews Rheumatology 2011;7(1):33-42.
3. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine 2001;344(12):907-16.
4. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis and Rheumatism 2001;44(6):1237-47.
5. Amin AR, Abramson SB. The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Current Opinion in Rheumatology 1998;10(3):263-8.
6. Abramson SB, Attur M, Amin AR, Clancy R. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Current Rheumatology Reports 2001;3(6):535-41.
7. Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Research and Therapy 2008;10(Suppl. 2):S2.
8. Okeson JP. Management of temporomandibular disorders and occlusion. 5th ed. Mosby: St. Louis; 2003.
9. Guler AD, Lee H, Iida T, Shimizu I, Tominaga M, Caterina M. Heat-evoked activation of the ion channel, TRPV4. The Journal of Neuroscience The Official Journal of the Society for Neuroscience 2002;22(15):6408-14.
10. Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A, et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000;103(3):525-35.
11. Alessandri-Haber N, Yeh JJ, Boyd AE, Parada CA, Chen X, Reichling DB, et al. Hypotonicity induces TRPV4-mediated nociception in rat. Neuron 2003;39(3):497-511.
12. Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. Journal of Biological Chemistry 2003;278(25):22664-8.
13. Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, et al. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. The Journal of Physiology 2007;578(Pt 3):715-33.
14. Suzuki M, Watanabe Y, Oyama Y, Mizuno A, Kusano E, Hirao A, et al. Localization of mechanosensitive channel TRPV4 in mouse skin. Neuroscience Letters 2003;353(3):189-92.
15. Phan MN, Leddy HA, Votta BJ, Kumar S, Levy DS, Lipshutz DB, et al. Functional characterization of TRPV4 as an osmotically sensitive ion channel in porcine articular chondrocytes. Arthritis and Rheumatism 2009;60(10):3028-37.
16. Clark AL, Votta BJ, Kumar S, Liedtke W, Guilak F. Chondroprotective role of the osmotically sensitive ion channel transient receptor potential vanilloid 4: age- and sex-dependent progression of osteoarthritis in TRPV4-deficient mice. Arthritis and Rheumatism 2010;62(10):2973-83.
17. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocrine Reviews 2002;23(1):90-119.
18. Le Bail J, Liagre B, Vergne P, Bertin P, Beneytout J, Habrioux G. Aromatase in synovial cells from postmenopausal women. Steroids 2001;66(10):749-57.
19. Badger AM, Blake SM, Dodds RA, Griswold DE, Swift BA, Rieman DJ, et al. Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvantinduced arthritis. Journal of Pharmacology and Experimental Therapeutics 1999;291(3):1380-6.
20. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. International Journal of Cancer 2008;123(2):372-9.
21. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, et al. Micro-RNA profiling in kidney and bladder cancers. Urologic Oncology 2007;25(5):387-92.
22. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. International Journal of Cancer 2010;126(1):73-80.
23. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT. MicroRNA profiling of human kidney cancer subtypes. International Journal of Oncology 2009;35(1):109-14.
24. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. The Journal of the American Medical Association 2008;299(4):425-36.
25. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumorsuppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010;31(5):766-76.
26. Kozaki KI, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Research 2008;68(7):2094-105.
27. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, et al. MicroRNA expression profiles of esophageal cancer. The Journal of Thoracic and Cardiovascular Surgery 2008;135(2):255-60.
28. Sonkoly E, Wei TL, Janson PCJ, Saaf A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2007;2(7).
29. Moffatt CE, Lamont RJ. Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infection and Immunity 2011;79(7):2632-7.
30. Stanczyk J, Ospelt C, Karouzakis E, Filer A, Raza K, Kolling C, et al. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis and Rheumatism 2011;63(2):373-81.
31. Tomaszewska A, Guevara I, Wilczok T, Dembinska-Kiec A. 17beta-estradiol- and lipopolysaccharide-induced changes in nitric oxide, tumor necrosis factor-alpha and vascular endothelial growth factor release from RAW 264.7 macrophages. Gynecologic and Obstetric Investigation 2003;56(3):152-9.
32. Beauregard C, Brandt P. Down regulation of interleukin-1beta-induced nitric oxide production in lacrimal gland acinar cells by sex steroids. Current Eye Research 2004;29(1):59-66.
33. Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. Journal of Neuroimmunology 2000;111(1-2):77-85.
34. Vegeto E, Pollio G, Ciana P, Maggi A. Estrogen blocks inducible nitric oxide synthase accumulation in LPS-activated microglia cells. Experimental Gerontology 2000;35(9-10):1309-16.
35. Bahamonde MI, Fernandez-Fernandez JM, Guix FX, Vazquez E, Valverde MA. Plasma membrane voltage-dependent anion channel mediates antiestrogen-activated maxi Cl-currents in C1300 neuroblastoma cells. Journal of Biological Chemistry 2003;278(35):33284-9.
36. 2+ channels in rat renal cells. Steroids 2009;74(8):642-9.
37. Senti M, Fernandez-Fernandez JM, Tomas M, Vazquez E, Elosua R, Marrugat J, et al. Protective effect of the KCNMB1 E65K genetic polymorphism against diastolic hypertension in aging women and its relevance to cardiovascular risk. Circulation Research 2005;97(12):1360-5.
38. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, et al. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 1999;285(5435):1929-31.
39. Chang AS, Chang SM, Garcia RL, Schilling WP. Concomitant and hormonally regulated expression of trp genes in bovine aortic endothelial cells. FEBS Letters 1997;415(3):335-40.
40. Bidaux G, Roudbaraki M, Merle C, Crepin A, Delcourt P, Slomianny C, et al. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. Endocrine-Related Cancer 2005;12(2):367-82.
41. Bolanz KA, Hediger MA, Landowski CP. The role of TRPV6 in breast carcinogenesis. Molecular Cancer Therapeutics 2008;7(2):271-9.
42. Jung C, Fandos C, Lorenzo IM, Plata C, Fernandes J, Gene GG, et al. The progesterone receptor regulates the expression of TRPV4 channel. Pflugers Archiv European Journal of Physiology 2009;459(1):105-13.
43. Séguin CA, Bernier SM. TNFalpha suppresses link protein and type II collagen expression in chondrocytes: role of MEK1/2 and NF-kappaB signaling pathways. Journal of Cellular Physiology 2003;197(3):356-69.